Moderna Inc. (MRNA): Price and Financial Metrics
MRNA Price/Volume Stats
| Current price | $58.72 | 52-week high | $170.47 |
| Prev. close | $60.20 | 52-week low | $58.33 |
| Day low | $58.33 | Volume | 5,021,300 |
| Day high | $60.65 | Avg. volume | 4,341,448 |
| 50-day MA | $78.08 | Dividend yield | N/A |
| 200-day MA | $104.86 | Market Cap | 22.50B |
MRNA Stock Price Chart Interactive Chart >
Moderna Inc. (MRNA) Company Bio
Moderna, Inc. (/məˈdɜːrnə/ mə-DUR-nə) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to produce an immune response. (Source:Wikipedia)
MRNA Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...